Analysis of combination anti-angiogenesis therapy on markers of coagulation, platelet activation and angiogenesis in patients with advanced cancer

Cancer Letters

Volumn 219, Issue 2, 2005, Pages 163-167

  Caine, G J ^a   Harris, A L ^b   Christodoulos, K ^b   Lip, G Y H ^a   Blann, A D ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

^b CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Angiogenesis; Platelets; Soluble P selectin; Tissue factor; VEGF

Indexed keywords

ANGIOGENESIS INHIBITOR; BIOCHEMICAL MARKER; CAPTOPRIL; DALTEPARIN; MARIMASTAT; PADGEM PROTEIN; THROMBOPLASTIN; VASCULOTROPIN;

ADULT; ADVANCED CANCER; AGED; ANGIOGENESIS; ARTICLE; BLADDER CARCINOMA; BLOOD CLOTTING; BLOOD SAMPLING; CLINICAL ARTICLE; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; DRUG EFFECT; FEMALE; HUMAN; KIDNEY CARCINOMA; LUNG CARCINOMA; MALE; MELANOMA; MESOTHELIOMA; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SIGMOID CARCINOMA; STOMACH CARCINOMA; THROMBOCYTE ACTIVATION; TRANSITIONAL CELL CARCINOMA; UTERINE CERVIX CARCINOMA;

EID: 13944269851     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2004.09.036     Document Type: Article

References (31)

1. G.Y.H. Lip, B.S.P. Chin, and A.D. Blann Cancer and the prothrombotic state Lancet Oncol. 3 2002 27 34
2. M. Roselli, T.C. Mineo, S. Basili, S. Mariotti, F. Martini, and A. Bellotti Vascular endothelial growth factor (VEGF-A) plasma levels in non-small cell lung cancer: relationship with coagulation and platelet activation markers Thromb. Haemost. 89 2003 177 184
3. I. Muller, A. Klocke, M. Alex, M. Kotzsch, T. Luther, and E. Morgenstern Intra-vascular tissue factor initiates coagulation via circulating microvesicles and platelets Fed. Am. Soc. Exp. Biol. J. 17 2003 476 478
4. H.M. Verheul, K. Hoekman, F. Lupu, H.J. Broxterman, P. Van der Valk, A.K. Kakkar, and H.M. Pinedo Platelet and coagulation activation with vascular endothelial growth factor generation in soft tissue sarcomas Clin. Cancer Res. 6 2000 166 171
5. F.R. Rickles, M. Shoji, and K. Abe The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer Int. J. Hematol. 73 2001 145 150
6. J. Contrino, G. Hair, D.L. Kreutzer, and F.R. Rickles In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of breast disease Nat. Med. 2 1996 209 215
7. T. Nakasaki, H. Wada, C. Shigemori, C. Miki, E.C. Gabazza, T. Nobori, S. Nakamura, and H. Shiku Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer Am. J. Hematol. 69 2002 247 254
8. S. Takano, K. Tsuboi, Y. Tomono, Y. Mitsui, and T. Nose Tissue factor, osteopontin, alphavbeta3 integrin expression in microvasculature of gliomas associated with vascular endothelial growth factor expression Br. J. Cancer 82 2000 1967 1973
9. S.A. Abdulkadir, G.F. Carvalhal, Z. Kaleem, W. Kisiel, P.A. Humphrey, W.J. Catalona, and J. Milbrandt Tissue factor expression and angiogenesis in human prostate carcinoma Hum. Pathol. 31 2000 443 447
10. H.M. Verheul, K. Hoekman, S. Luykx-de Bakker, C.A. Eekman, C.C. Folman, H.J. Broxterman, and H.M. Pinedo Platelet: transporter of vascular endothelial growth factor Clin. Cancer Res. 3 1997 2187 2190
11. H.F. Dvorak, L.F. Brown, M. Detmar, and A.M. Dvorak Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis Am. J. Pathol. 146 1995 1029 1039
12. F.M. Belgore, G.Y. Lip, D. Bareford, M. Wadley, P. Stonelake, and A.D. Blann Plasma levels of vascular endothelial growth factor (VEGF) and its receptor, Flt-1, in haematological cancers: a comparison with breast cancer Am. J. Hematol. 66 2001 59 61
13. A.D. Blann, D. Gurney, M. Wadley, D. Bareford, P. Stonelake, and G.Y. Lip Increased soluble P-selectin in patients with haematological and breast cancer: a comparison with fibrinogen, plasminogen activator inhibitor and von Willebrand factor Blood Coagul. Fibrinol. 12 2001 43 50
14. D. Gurney, C. Poole, S. Kehoe, G.Y. Lip, and A.D. Blann Soluble P-selectin is influenced by cancer chemotherapy Platelets 12 2001 37 38
15. O.V. Volpert, W.F. Ward, M.W. Lingen, L. Chesler, D.B. Solt, and M.D. Johnson Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats J. Clin. Invest. 98 1996 671 679
16. S.I. Hii, D.L. Nicol, D.C. Gotley, L.C. Thompson, M.K. Green, and J.R. Jonsson Captopril inhibits tumour growth in a xenograft model of human renal cell carcinoma Br. J. Cancer 77 1998 880 883
17. C. Prontera, B. Mariani, C. Rossi, A. Poggi, and D. Rotilio Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma Int. J. Cancer 81 1999 761 766
18. V.M. Macaulay, K.J. O'Byrne, J.P. Braybrooke, L. Long, and F. Gleeson Phase I study of intrapleural batimastat (BB-94), a matrix metalloproteinase inhibitor, in the treatment of malignant pleural effusions Clin.Cancer Res. 5 1999 513 520
19. S. Wojtowicz-Praga, J. Torri, M. Johnson, V. Steen, J. Marshall, and E. Ness Phase I trial of Marimastat, a novel matrix metalloproteinase inhibitor, administered orally to patients with advanced lung cancer J. Clin. Oncol. 16 1998 2150 2156
20. J. Folkman, R. Langer, R.J. Linhardt, C. Haudenschild, and S. Taylor Angiogenesis inhibition and tumor regression caused by heparin or a heparin fragment in the presence of cortisone Science 221 1983 719 725
21. T. Ueno, M. Toi, M. Koike, S. Nakamura, and T. Tominaga Tissue factor expression in breast cancer tissues: its correlation with prognosis and plasma concentration Br. J. Cancer 83 2000 164 170
22. Y. Forster, A. Meye, S. Albrecht, M. Kotzsch, S. Fussel, M.P. Wirth, and B. Schwenzer Tissue specific expression and serum levels of human tissue factor in patients with urological cancer Cancer Lett. 193 2003 65 73
23. G.J. Caine, A.D. Blann, P.S. Stonelake, P. Ryan, and G.Y. Lip Plasma angiopoietin-1, angiopoietin-2 and Tie-2 in breast and prostate cancer: a comparison with VEGF and Flt-1 Eur. J. Clin. Invest. 33 2003 883 890
24. S.Y. Lin, Y.Y. Wang, and W.H. Sheu Preoperative plasma concentrations of vascular endothelial growth factor and matrix metalloproteinase 9 are associated with stage progression in papillary thyroid cancer Clin. Endocrinol. 58 2003 513 518
25. A. Aguayo, H.M. Kantarjian, E.H. Estey, F.J. Giles, S. Verstovsek, and T. Manshouri Plasma VEGF levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes Cancer 95 2002 1923 1930
26. M. Shoji, W.W. Hancock, K. Abe, C. Micko, K.A. Casper, and R.M. Baine Activation of coagulation and angiogenesis in cancer: immunohistochemical localization in situ of clotting proteins and VEGF in human cancer Am. J. Pathol. 152 1998 399 411
27. K. Abe, M. Shoji, J. Chen, A. Bierhaus, I. Danave, and C. Micko Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor Proc. Natl Acad. Sci. USA 96 1999 8663 8668
28. T. Nakasaki, H. Wada, C. Shigemori, C. Miki, E.C. Gabazza, and T. Nobori Expression of tissue factor and vascular endothelial growth factor is associated with angiogenesis in colorectal cancer Am. J. Hematol. 69 2002 247 254
29. R.T. Poon, C.P. Lau, J.W. Ho, W.C. Yu, S.T. Fan, and J. Wong Tissue factor expression correlates with tumour angiogenesis and invasiveness in human hepatocellular carcinoma Clin. Cancer Res. 9 2003 5339 5345
30. D.F. Altomare, M.T. Rotelli, V. Memeo, E. Martinelli, A. Guglielmi, and M. DeFazio Expression of tissue factor and vascular endothelial growth factor in colorectal carcinoma Tumori 89 2003 5 6
31. B.C. Kuenen, M. Levi, J.C. Meijers, A.K. Kakkar, V.W. van Hinsbergh, and P.J. Kostense Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients Arterioscler. Thromb. Vasc. Biol. 22 2002 1500 1505